Zymeworks, Inc. (ZYME)
25.84
+0.04
(+0.16%)
USD |
NASDAQ |
Apr 06, 16:00
25.85
+0.01
(+0.04%)
After-Hours: 20:00
Zymeworks SG&A Expense (TTM) : 61.51M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Royalty Pharma Plc | 573.21M |
| Krystal Biotech, Inc. | 146.91M |
| Scholar Rock Holding Corp. | 176.20M |
| Xeris Biopharma Holdings, Inc. | 182.37M |
| Stoke Therapeutics, Inc. | 67.09M |